Mobia Medical, Inc.
Filed Apr 17, 2026.
View on SEC.govAbout this filing
A company's registration of shares for sale to the public, often for a first offering. It describes the business, its risks and how the company plans to use the money.
period unavailable · Filed Apr 17, 2026
Contents
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
This prospectus contains forward-looking statements. All statements other than statements of historical facts contained in this prospectus, including statements regarding our future liquidity, business strategy, clinical trials and clinical strategy, prior authorization and reimbursement strategy, real-world patient registries, as well as plans and objectives of management for future operations, are forward-looking statements. These statements involve known and unknown risks, uncertainties and other important factors that are in some cases beyond our control and may cause our actual results, performance, or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.
In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “would,” “expect,” “plan,” “anticipate,” “could,” “intend,” “target,” “project,” “contemplate,” “believe,” “estimate,” “predict,” “potential,” or “continue” or the negative of these terms or other similar expressions. Forward-looking statements contained in this prospectus include, but are not limited to, statements about:
the expected growth of our business and our organization;
our ability to retain and recruit key personnel, including the continued development of a sales and marketing infrastructure;
our expectations regarding the potential market size and size of the potential patient populations for Vivistim Therapy and any future products, if approved for commercial use;
the expected use of our products by physicians and patients;
our plans to conduct further clinical trials and patient registries;
our plans and expected timeline enhancing related to our products, or developing new products, to address additional indications or otherwise;
our ability to obtain, maintain and expand regulatory clearances for our products and any new products we create;
our expected uses of the net proceeds from this offering and our existing cash and cash equivalents;
our expectations regarding government and third-party payer coverage and reimbursement;
our ability to purchase sufficient quantities from manufacturers of our products with sufficient quality and at an acceptable price;
our ability to obtain an adequate supply of materials and components for our products from our third-party suppliers;
our ability to obtain, maintain and enforce intellectual property protection for our products;
our ability to expand our business into new geographic markets;
the outcome of any litigations to which we may become a party;
our compliance with extensive exchange requirements and government laws, rules, and regulations both in the United States and internationally;
our estimates of our expenses, ongoing losses, future revenue, and capital requirements, as well as our need for, or ability to obtain, additional financing, and our future financial performance;
our ability to identify and develop new and planned products or acquire new products;
developments and projections relating to our competitors or our industry; and
You should not rely upon forward-looking statements as predictions of future events. We have based the forward-looking statements contained in this prospectus primarily on our current expectations, estimates, forecasts, and projections about future events and trends that we believe may affect our business, financial condition, results of operations, and prospects. Although we believe that we have a reasonable basis for each forward-looking statement contained in this prospectus, we cannot guarantee that the future results, levels of activity, performance, or events and circumstances reflected in the forward-looking statements will be achieved or occur at all. The outcome of the events described in these forward-looking statements is subject to risks, uncertainties, and other factors described in the section titled “Risk Factors” and elsewhere in this prospectus. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and risks and uncertainties that we currently deem immaterial may also impair our business operations and the market price for our common stock, and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this prospectus. The results, events, and circumstances reflected in the forward-looking statements may not be achieved or occur, and actual results, events, or circumstances could differ materially from those described in the forward-looking statements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.